Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Plos One
|
March 30, 2012
SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids
Paul Mason, Beirong Liang, Lingyun Li, et al.
ACS Chemical Biology
|
April 3, 2019
Small Molecule and Pooled CRISPR Screens Investigating IL17 Signaling Identify BRD2 as a Novel Contributor to Keratinocyte Inflammatory Responses
Peter F Slivka, Chen-Lin Hsieh, Alex Lipovsky, et al.
Clinical and Translational Gastroenterology
|
December 15, 2012
Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease
Corinne Cayatte, Barbara Joyce-Shaikh, Felix Vega, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
October 3, 2024
Nutcracker syndrome (a Delphi consensus)
Floor Heilijgers, Peter Gloviczki, Gerry O'Sullivan, et al.
Molecular and Cellular Neurosciences
|
March 6, 2007
The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease
David R Riddell, Hua Zhou, Thomas A Comery, et al.
Science (New York, N.Y.)
|
October 13, 2018
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy
Razvan Cristescu, Robin Mogg, Mark Ayers, et al.
Cancer
|
May 3, 2017
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas
Seth M Pollack, Qianchuan He, Jennifer H Yearley, et al.
Cancer Cell
|
December 17, 2011
IL-10 elicits IFNγ-dependent tumor immune surveillance
John B Mumm, Jan Emmerich, Xueqing Zhang, et al.
Chemistry & Biology
|
September 25, 2012
Small molecule activation of PKM2 in cancer cells induces serine auxotrophy
Charles Kung, Jeff Hixon, Sung Choe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells
Peter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Plos One
|
March 30, 2012
SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids
Paul Mason, Beirong Liang, Lingyun Li, et al.
ACS Chemical Biology
|
April 3, 2019
Small Molecule and Pooled CRISPR Screens Investigating IL17 Signaling Identify BRD2 as a Novel Contributor to Keratinocyte Inflammatory Responses
Peter F Slivka, Chen-Lin Hsieh, Alex Lipovsky, et al.
Clinical and Translational Gastroenterology
|
December 15, 2012
Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease
Corinne Cayatte, Barbara Joyce-Shaikh, Felix Vega, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
October 3, 2024
Nutcracker syndrome (a Delphi consensus)
Floor Heilijgers, Peter Gloviczki, Gerry O'Sullivan, et al.
Molecular and Cellular Neurosciences
|
March 6, 2007
The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease
David R Riddell, Hua Zhou, Thomas A Comery, et al.
Science (New York, N.Y.)
|
October 13, 2018
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy
Razvan Cristescu, Robin Mogg, Mark Ayers, et al.
Cancer
|
May 3, 2017
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas
Seth M Pollack, Qianchuan He, Jennifer H Yearley, et al.
Cancer Cell
|
December 17, 2011
IL-10 elicits IFNγ-dependent tumor immune surveillance
John B Mumm, Jan Emmerich, Xueqing Zhang, et al.
Chemistry & Biology
|
September 25, 2012
Small molecule activation of PKM2 in cancer cells induces serine auxotrophy
Charles Kung, Jeff Hixon, Sung Choe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells
Peter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Page
of 9